Crossmark

Biomarkers for response to TIL therapy: a comprehensive review

Crossref DOI link: https://doi.org/10.1136/jitc-2023-008640

Published Online: 2024-03-13

Published Print: 2024-03

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Albarrán Fernández, Víctor https://orcid.org/0000-0001-6356-2551
Ballestín Martínez, Pablo https://orcid.org/0009-0000-7200-0155
Stoltenborg Granhøj, Joachim

Borch, Troels Holz https://orcid.org/0000-0002-4402-9281
Donia, Marco https://orcid.org/0000-0003-4966-9752
Marie Svane, Inge
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct04611126 at ClinicalTrials.gov

Documents that mention this clinical trial

Biomarkers for response to TIL therapy: a comprehensive review
https://doi.org/10.1136/jitc-2023-008640
License Information

License valid from 2024-03-13